Simplex Trading
PGNX

Simplex Trading’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Simplex Trading’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5
Closed -$1K – 8775
2020
Q1 		$1K Sell
5
-45
-90% -$194 ﹤0.01% 7481
2019
Q4 		$25K Buy
50
+25
+100% +$132 ﹤0.01% 5805
2019
Q3 		$12K Sell
25
-155
-86% -$773 ﹤0.01% 6173
2019
Q2 		$111K Buy
180
+122
+210% +$588 ﹤0.01% 4079
2019
Q1 		$26K Buy
58
+39
+205% +$176 ﹤0.01% 5546
2018
Q4 		$7K Hold
19
– – ﹤0.01% 6094
2018
Q3 		$11K Sell
19
-112
-85% -$860 ﹤0.01% 6389
2018
Q2 		$105K Sell
131
-62
-32% -$473 ﹤0.01% 4237
2018
Q1 		$22K Buy
193
+181
+1,508% +$1.2K ﹤0.01% 3285
2017
Q4 		$1K Sell
12
-196
-94% -$1.19K ﹤0.01% 5781
2017
Q3 		$2K Buy
208
+178
+593% +$1.13K ﹤0.01% 5260
2017
Q2 		$2K Sell
30
-2
-6% -$15 ﹤0.01% 5423
2017
Q1 		$6K Sell
32
-15
-32% -$150 ﹤0.01% 4503
2016
Q4 		$6K Buy
47
+8
+21% +$59 ﹤0.01% 4265
2016
Q3 		$1K Hold
39
– – ﹤0.01% 5550
2016
Q2 		$1K Buy
+39
New +$188 ﹤0.01% 5566

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Simplex Trading's PGNX Position: Q2 2020 in Review

Simplex Trading sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 200 shares.

Simplex Trading first reported a position in PGNX in Q1 2015 and held it in 16 quarters. The position peaked at $182K in Q3 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Simplex Trading reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Simplex Trading sold 200 Progenics Pharmaceuticals Inc shares in Q2 2020.
  • Simplex Trading first reported a position in Progenics Pharmaceuticals Inc in Q1 2015 and held it in 16 quarters.
  • Simplex Trading's Progenics Pharmaceuticals Inc position peaked at $182K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Simplex Trading's 13F filing for Q2 2020, filed 13 Jul 2020.